Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results
LCDIProcessed 2,756 EsoGuard® tests and recognized 2Q25 revenue of $1.2 million, ending quarter with over $30 million in proforma cash and extending runway well past upcoming reimbursement milestones Multi-Jurisdictional Contractor Advisory Committee (CAC) meeting on Medicare Local Coverage...
August 13, 2025Earnings
Read more →